policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
The hidden ecosystem of the gut microbiome
Millions of bacteria live in the gastrointestinal tract of animals, including cats, dogs, and humans.
JAVMA news
1935 - 1945
Information on food-producing animals was a mainstay of JAVMA during this decade.
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
JAVMA news
Taking on obesity as a disease
The veterinary profession should formally recognize canine and feline obesity as a disease, according to a position statement from the Global Pet…